Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement upon the U.S. Senate’s vote to confirm Dr. Robert Califf as FDA Commissioner.
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement upon the U.S. Senate’s vote to confirm Dr. Robert Califf as FDA Commissioner.
The Healthcare Distribution Alliance (HDA) issued the following statement today from HDA Senior Vice President of State Government Affairs and Alliance Development Matt DiLoreto, upon introduction of SB 823 and HB 973 by the Maryland Legislature.
The HDA Research Foundation announced Craig Cowman of Cardinal Health as Chairman of its Board of Directors. Stephen O’Dowd of Eisai, Inc., is Vice Chairman.
The Healthcare Distribution Alliance (HDA) released the following statement from President and CEO Chester “Chip” Davis Jr., regarding FDA’s proposed rule, issued as required by the Drug Supply Chain Security Act (DSCSA), entitled “National Standards for Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers.”
The HDA Research Foundation today announces it has awarded graduate-level scholarships to four pharmaceutical supply chain leaders. The program was recently renamed to honor Karen J. Ribler, the Foundation’s former COO who led the organization for nearly 10 years; Ms. Ribler passed away in June 2021.
John Parker
(703) 885-0216
Farah Simonett
(703) 885-0269